CAMPBELL -
An audio webcast of the presentation will be available in the events and presentations section of the Company's investor relations website, or by clicking here.
About VIVUS
VIVUS is a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs.
Forward-Looking Statements
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as 'anticipate,' 'believe,' 'forecast,' 'estimate,' 'expect,' 'intend,' 'likely,' 'may,' 'plan,' 'potential,' 'predict,' 'opportunity' and 'should,' among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ended
Contact:
Tel: 650-934-5200
Email: oki@vivus.com
(C) 2019 Electronic News Publishing, source